CSPC Pharmaceutical Group Limited
OTC: CSPCY0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Lei Cai
- Employees
- 19,700
- Headquarters
- Shijiazhuang, China
- IPO year
- 2021
- Market cap
- $10.1B
- Website
- https://www.cspc.com.hk
Loading CSPCY…
Loading profile data…Frequently asked questions about CSPCY
What does CSPC Pharmaceutical Group Limited (CSPCY) do?
CSPC Pharmaceutical Group Limited, an investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally. It operates through Finished Drugs, Bulk Products, and Functional Food and Others segments. The company provides NBP soft capsules and...
Where does CSPCY trade?
CSPC Pharmaceutical Group Limited (CSPCY) trades on the Other OTC.
What sector is CSPCY in?
CSPC Pharmaceutical Group Limited (CSPCY) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of CSPC Pharmaceutical Group Limited?
Lei Cai is the chief executive officer of CSPC Pharmaceutical Group Limited (CSPCY).
Where is CSPC Pharmaceutical Group Limited headquartered?
CSPC Pharmaceutical Group Limited is headquartered in China.
Does CSPCY pay a dividend?
Yes — CSPC Pharmaceutical Group Limited (CSPCY) paid a trailing twelve-month dividend of USD 0.07 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did CSPCY go public?
CSPC Pharmaceutical Group Limited (CSPCY) completed its initial public offering in 2021.